VivoSeq
Other

Aged

0

Pipeline Programs↗

5

Active Trials↗

7

Companies Involved↗

Aged is an early-stage landscape with 0 programs across 7 companies. The most active players are Novartis, Pfizer, Merck & Co..

Intelligence

Pipeline Metrics

Competitive Density

19/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

87/100

Attrition Rate

6/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Novartis logo

Novartis

0 programs

PreclinicalPfizer logo

Pfizer

0 programs

PreclinicalMerck & Co. logo

Merck & Co.

0 programs

PreclinicalBayer logo

Bayer

0 programs

PreclinicalDaiichi Sankyo logo

Daiichi Sankyo

0 programs

PreclinicalGSK logo

GSK

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

32

clinical trials

Completed13 · 41%
Available8 · 25%
No longer available3 · 9%
Recruiting2 · 6%
Active, not recruiting1 · 3%
Terminated1 · 3%
Other4 · 13%

Clinical Trials

Trial Activity

32 trials

Impacts of Mechanistic Target of Rapamycin (mTOR) Inhibition on Aged Human Muscle (Rapamune)
Recruiting·UUniversity of Nottingham·N/A·NCT05414292·16 enrolled
Post-Transplant Cyclophosphamide in Patients Aged >/= 65 Years Undergoing Haploidentical Transplant
Recruiting·—·Phase 1·NCT05849207·26 enrolled
SPECIAL INVESTIGATION FOR ABRYSVO IN INDIVIDUALS AGED 60 YEARS OR OLDER
Active, not recruiting·Pfizer logoPfizer·N/A·NCT06546800·1,100 enrolled
Bioengineered Penile Tissue Constructs for Irreversibly Damaged Penile Corpora
Not yet recruiting·WWake Forest University Health Sciences·Phase 1·NCT03463239·10 enrolled
Evaluation of Tretinoin Cream on the Integrity of Aged Forearm Skin
Enrolling by invitation·SStanford University·Phase 2/3·NCT07084116·30 enrolled
Bioavailability of Variably Aged MK-0974 Tablets (MK-0974-038)(COMPLETED)
Completed·Merck & Co. logoMerck & Co.·Phase 1·NCT01209741·48 enrolled
Daylight-PDT With MAL for AK and Photodamaged Skin
Completed·UUniversity Hospital Regensburg·Phase 4·NCT02736760·58 enrolled
Evaluate Safety of GCFLU® Administered Intramuscularly in Healthy Vietnamese Volunteer Aged From 3 Years Old
Completed·IInstitute of Clinical Research and Clinical Trial Support for Vaccine and Biological Products·Phase 4·NCT02723812·120 enrolled
A Study to Learn About the Taste of Vericiguat Given in Liquid Form in Healthy Male Participants Aged 18 to 45 Years
Completed·Bayer logoBayer·Phase 1·NCT06474208·19 enrolled
Study of DU-176b Aged 80 Years or Older
Completed·Daiichi Sankyo logoDaiichi Sankyo·Phase 3·NCT02801669·984 enrolled
Cognitive Effects of Darifenacin and Oxybutynin Extended Release in Volunteers Aged 60 and Over
Completed·Novartis logoNovartis·Phase 2·NCT00170768·150 enrolled
Comparison of Lantus and Neutral Protamine Hagedorn (NPH) Insulin in the Dawn Phenomenon
Completed·MMassachusetts General Hospital·Phase 3·NCT00694122·27 enrolled
Study to Monitor the Safety and Reactogenicity of Fluarix™ in Korean Subjects Aged > 6 Months of Age.
Completed·GSK logoGSK·Phase 4·NCT00750360·883 enrolled
FSME IMMUN NEW Follow-up to Study 208 in Volunteers Aged 16 to 66 Years
Completed·Pfizer logoPfizer·Phase 3·NCT00161876·3,973 enrolled
Clinical and Histologic Evaluation of Picato 0.15% Gel in the Cosmetic Improvement of Photoaged Skin
Completed·SSkin Laser & Surgery Specialists·N/A·NCT03508856·23 enrolled
Page 1 of 3

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)